Exothera selected to develop a large-scale manufacturing process
Vaccizone selects Exothera for process development and GMP manufacturing of its SARS‑CoV‑2 vaccine
Rokote selects Exothera for COVID vaccine manufacturing
Exothera receives GMP certification in Belgium
IDT Biologika enlists Exothera for viral vaccine scale-up
Genequine selects Exothera to help scale up gene therapy candidate
Does gene therapy have the answer to vaccinating the world?
